Synucleinopathies trials recruiting in Kansas

Fewer than 3 recruiting trials found.

All Synucleinopathies trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Kansas: Fairway